DRG uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.

Solutions › Medtech Solutions

Medtech Solutions

Formerly known as Millennium Research Group, our Medtech Solutions provide top insights for medical device markets across the globe. These solutions assist in providing overviews and inpatient tracking. With a focus on the medical technology industry, using insights from our experts globally, we ensure timely, relevant, and actionable insights for informing decisions at crucial decision points.

Learn more

Insights for global markets

Marketrack

Unbeatable dynamic brand-level market data

Marketrack provides ongoing brand-level market share data from facilities in 35 countries and 20 Medtech markets around the world, within 15 days of the end of the month or quarter.

Learn More

Procedure Finder 2.0

Procedure Finder 2.0 is a claims-based tool that provides U.S. facility-level procedure volumes for hospitals, health systems, and physicians & surgeons.

Learn More

Medtech 360

Analyzing the market outlook for global medical devices.

Medtech 360 report provides data and insights on the current state of a specific global medtech market, as well as market forecasts ten years into the future.

Search reports

AMR Imaging

Market intelligence for diagnostic imaging

AMR Imaging provides tracking of imaging procedure volumes, enhancement rates, contract usage, and patient demographics.

Learn more

PriceTrack

In-depth analysis of prices paid by hospitals revealing competitor pricing strategies

PriceTrack provides market share tracking and detailed pricing analysis at the SKU level in US hospitals.

Learn More

Our latest thoughts and commentary

Latest articles

Highlights from ADA 2017: So Many Sweet Results!

This year’s American Diabetes Association (ADA) meeting took place in San Diego, California from June 9th to June 13th. The...

In DRG Blog / Jun, 2017

Evolving clinical trial designs in Alzheimer’s disease: A double-edge sword?

With repeated clinical-stage failures in the past 15 years, drug development in Alzheimer’s disease (AD) defines “hard.” Yet...

In DRG Blog / Jun, 2017

Novartis’s next-generation VEGF inhibitor RTH-258 (brolucizumab) demonstrates non-inferiority to Eylea for wet AMD with less-frequent dosing. What does this mean for the wet AMD market?

Novartis announced top-line results on June 20th, 2017 from two Phase III clinical trials of RTH-258 (brolucizumab) indicating...

In DRG Blog, Drug Watch / Jun, 2017

CMS Taps the Breaks Again on MACRA

Proposed rules released by CMS concerning the Medicare Access and CHIP Reauthorization Act contain some notable changes for the...

In DRG Blog, Drug Watch, Health Reform / Jun, 2017

Paradox of choice: Are multiple treatment options in renal cell carcinoma presenting opportunities or indecisiveness?

June 22, 2017 will be the first World Kidney Cancer Q&A Day, where international kidney cancer communities in collaboration...

In DRG Blog, Drug Watch, Health Reform / Jun, 2017

News articles citing DRG analysts data.

FierceBiotech
Jun 13, 2017
Medical Design & Outsourcing
Apr 10, 2017
S&P Global Market Intelligence
Mar 28, 2017
Healthcare finance news
Mar 13, 2017

More News

Related Content

Executive Briefings

Carving Out a Share of the Robotic Surgery Market: The US Perspective

Robotic surgery has established a significant presence in today’s operating rooms and will become increasingly intertwined with the operating rooms of tomorrow. Medical device companies can...
E-Books

Success Drivers in the Commercialization of Digitally Enabled Medical Products

The need for personalized digital data is rapidly increasing and informing the development of technologies that target some of the biggest challenges in effective healthcare delivery. Our eBook...
White Papers

Convergence Drivers in the Biopharmaceutical and Medical Device Industries

Biopharma-medtech convergence drivers: 1. Miniaturization and continued adoption of minimally invasive (MI) approaches 2. Continued demand and development of combination products 3. Development and...

Search Reports

Reports are available across 1000s of drug, treatment, and indication areas.

Advanced Search

Connect

Reports search

Research & Data

Medtech Solutions